| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.7M | — | +1250.6% |
| R&D Expense | $6.9M | — | -19.3% |
| SG&A Expense | $4.2M | — | -0.5% |
| Operating Income | -$5.4M | — | +56.5% |
| Interest Expense | $100K | — | +0.0% |
| Net Income | -$5.2M | — | +57.8% |
| EPS (Basic) | -$1.08 | — | -535.3% |
| EPS (Diluted) | -$1.08 | — | -535.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.4M | -39.6% | +24.7% |
| Accounts Receivable | $5.4M | -3.5% | — |
| Current Assets | $26.4M | -28.6% | +65.7% |
| Total Assets | $30.9M | -26.9% | +38.7% |
| Current Liabilities | $7.4M | -45.2% | -52.3% |
| Total Liabilities | $9.3M | -41.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.9M | — | -33.9% |
| Capital Expenditures | $121K | — | -19.3% |
| Investing Cash Flow | -$121K | — | +19.3% |
| Financing Cash Flow | $306K | — | +130.6% |
| Free Cash Flow | -$11.1M | — | -32.9% |
| -40.9% |
| Stockholders' Equity | $21.6M | -18.3% | +228.4% |